0503.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (28 11月 2023 @ 17:08):

Stats
本日の出来高	13.96M
平均出来高	476 561
時価総額	750.60M
EPS	HKD0 ( 2023-08-24 )
Last Dividend	HKD1.497 ( 2021-09-13 )
Next Dividend	HKD0 ( N/A )
P/E	13.77
ATR14	HKD0.0150 (0.84%)

ボリューム相関

長: 0.09 (neutral)

短: 0.00 (neutral)

Signal:(54.908) Neutral

Lansen Pharmaceutical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Lansen Pharmaceutical 相関 - 通貨/商品

-0.27
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.05
( neutral )

-0.11
( neutral )

0.18
( neutral )

Lansen Pharmaceutical 財務諸表

Annual	2022
収益:	HKD65.56M
総利益:	HKD44.30M (67.57 %)
EPS:	HKD0.0205

FY	2022
収益:	HKD65.56M
総利益:	HKD44.30M (67.57 %)
EPS:	HKD0.0205

FY	2021
収益:	HKD54.18M
総利益:	HKD34.41M (63.51 %)
EPS:	HKD0.00224

FY	2020
収益:	HKD54.39M
総利益:	HKD35.18M (64.68 %)
EPS:	HKD0.218

Financial Reports:

No articles found.

Lansen Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Lansen Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.21 - good (82.09%) | Divividend Growth Potential Score: 2.16 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0136	2011-04-20
Last Dividend	HKD1.497	2021-09-13
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	HKD2.55	--
Avg. Dividend % Per Year	0.00%	--
Score	2.25	--
Div. Sustainability Score	8.21
Div.Growth Potential Score	2.16
Div. Directional Score	5.19	--

Next Divdend (Est)
(2024-07-15)

HKD0 Estimate 0.00 %

Dividend Stability

0.07 Very Bad

Dividend Score

2.25

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6033.HK	Ex Dividend Knight	2023-09-19	Semi-Annually	0.00%
1818.HK	Ex Dividend Junior	2023-06-07	Annually	0.00%
0848.HK	Ex Dividend Junior	2023-05-24	Annually	0.00%
0006.HK	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
2588.HK	Ex Dividend Knight	2023-09-25	Semi-Annually	0.00%
1382.HK	Ex Dividend Knight	2023-08-15	Semi-Annually	0.00%
0455.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
6823.HK	Ex Dividend Knight	2023-08-17	Semi-Annually	0.00%
1931.HK	Ex Dividend Knight	2023-09-04	Semi-Annually	0.00%
0966.HK	Ex Dividend Junior	2023-07-10	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.114	1.500	7.72	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0424	1.200	8.59	10.00	[0 - 0.3]
returnOnEquityTTM	0.0604	1.500	-0.440	-0.661	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.54	0.800	2.28	1.820	[1 - 3]
quickRatioTTM	1.500	0.800	5.88	4.71	[0.8 - 2.5]
cashRatioTTM	0.939	1.500	5.89	8.84	[0.2 - 2]
debtRatioTTM	0.101	-1.500	8.31	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.00596	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00460	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.144	-1.500	9.43	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.660	1.000	2.33	2.33	[0.2 - 0.8]
operatingProfitMarginTTM	0.191	1.000	8.18	8.18	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.142	1.000	-0.323	-0.323	[0.2 - 2]
assetTurnoverTTM	0.371	0.800	-0.859	-0.687	[0.5 - 2]
Total Score				8.21

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.03	1.000	8.78	0	[1 - 100]
returnOnEquityTTM	0.0604	2.50	-0.283	-0.661	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00460	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00596	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00938	1.500	-3.27	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0388	1.000	-1.530	0	[0.1 - 0.5]
Total Score				2.16

Lansen Pharmaceutical

Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty pharmaceuticals for use in the field of rheumatology and dermatology in the People's Republic of China and internationally. The company operates through Pharmaceuticals, Cosmetics Products, and Healthcare Products segments. It offers Chinese medicine generic drugs; cosmetic products; and healthcare products. The company was founded in 2001 and is headquartered in Ningbo, the People's Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.